KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Apr 29, 2026 >>  ABB India 7265  [ -0.34% ]  ACC 1436.6  [ -0.26% ]  Ambuja Cements 454.85  [ -0.94% ]  Asian Paints 2447.4  [ -0.62% ]  Axis Bank 1295.4  [ 0.47% ]  Bajaj Auto 9542.1  [ 0.52% ]  Bank of Baroda 268.25  [ 0.19% ]  Bharti Airtel 1887.95  [ 2.30% ]  Bharat Heavy 344.45  [ -2.97% ]  Bharat Petroleum 303.95  [ -1.22% ]  Britannia Industries 5709.75  [ 0.86% ]  Cipla 1316.65  [ 0.66% ]  Coal India 479.65  [ 2.72% ]  Colgate Palm 2132.15  [ 0.24% ]  Dabur India 456  [ 1.37% ]  DLF 594  [ 1.03% ]  Dr. Reddy's Lab. 1330.1  [ -1.82% ]  GAIL (India) 165.7  [ -0.03% ]  Grasim Industries 2802.2  [ 0.73% ]  HCL Technologies 1199.7  [ 0.29% ]  HDFC Bank 778.8  [ -0.45% ]  Hero MotoCorp 5111.55  [ 0.79% ]  Hindustan Unilever 2313.05  [ 1.08% ]  Hindalco Industries 1067.4  [ -0.64% ]  ICICI Bank 1280.5  [ -0.87% ]  Indian Hotels Co. 644.25  [ -1.19% ]  IndusInd Bank 913.6  [ 3.25% ]  Infosys 1167.5  [ 1.29% ]  ITC 316.2  [ 3.86% ]  Jindal Steel 1228.8  [ -2.89% ]  Kotak Mahindra Bank 381.6  [ 1.01% ]  L&T 4095.75  [ 1.45% ]  Lupin 2310.9  [ 0.38% ]  Mahi. & Mahi 3150.9  [ 2.04% ]  Maruti Suzuki India 13260.2  [ 2.86% ]  MTNL 31.44  [ -1.07% ]  Nestle India 1466.1  [ 1.82% ]  NIIT 70.73  [ -1.20% ]  NMDC 91.77  [ 0.98% ]  NTPC 401.15  [ -1.33% ]  ONGC 301.3  [ -0.02% ]  Punj. NationlBak 111.15  [ -0.22% ]  Power Grid Corpn. 320.35  [ 0.44% ]  Reliance Industries 1426.15  [ 2.68% ]  SBI 1086.4  [ -0.41% ]  Vedanta 773.25  [ 4.61% ]  Shipping Corpn. 307.75  [ 1.25% ]  Sun Pharmaceutical 1778.95  [ 1.79% ]  Tata Chemicals 800.35  [ -0.18% ]  Tata Consumer 1168.05  [ 1.74% ]  Tata Motors Passenge 352.35  [ 0.46% ]  Tata Steel 215.9  [ 0.40% ]  Tata Power Co. 451.8  [ -2.11% ]  Tata Consult. Serv. 2473.2  [ 1.17% ]  Tech Mahindra 1460.25  [ 3.63% ]  UltraTech Cement 11829.4  [ 0.11% ]  United Spirits 1362.5  [ -0.80% ]  Wipro 200.7  [ -0.47% ]  Zee Entertainment 90.46  [ -2.78% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    ALIVUS LIFE SCIENCES LTD.

    29 April 2026 | 12:00

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE03Q201024 BSE Code / NSE Code 543322 / ALIVUS Book Value (Rs.) 257.92 Face Value 2.00
    Bookclosure 01/09/2025 52Week High 1225 EPS 39.57 P/E 25.41
    Market Cap. 12341.14 Cr. 52Week Low 819 P/BV / Div Yield (%) 3.90 / 0.00 Market Lot 1.00
    Security Type Other

    History of Company

    The company history sections lists out major chronological events that happened to the company.
    The Company was incorporated as `Zorg Laboratories Private Limited', a private limited company under the Companies Act, 1956 on June 23, 2011 at Pune and was granted the certificate of incorporation by the RoC. the Company was acquired by Glenmark Pharmaceuticals Limited pursuant to the Share Purchase Agreement dated July 4, 2018. For further details, please see - "Details regarding material acquisitions or divestments of business/ undertakings, mergers, amalgamations or any revaluation of assets, in the last 10 years - Acquisition by Glenmark Pharmaceuticals Limited" on page 151. Pursuant to the acquisition, the name of the Company was changed to `Glenmark Life Sciences Private Limited' by way of a special resolution passed by the shareholders of the Company on July 25, 2018 and a fresh certificate of incorporation dated August 10, 2018 was issued by the RoC. A shareholders' resolution was passed on August 13, 2018 to convert the Company from a private limited company to a public limited company and a fresh certificate of incorporation dated August 28, 2018 was issued by the RoC. Thereafter, the business of active pharmaceutical ingredients was acquired by the Company from the Promoter pursuant to the Business Purchase Agreement.

    Major events and milestones of the Company :
    2002
    - The Promoter established its API business
    - Established manufacturing plant at Kurkumbh, Maharashtra

    2003
    - First product registered with US-FDA
    - Acquired GlaxoSmithKline's (GSK) API manufacturing plant in Ankleshwar, Gujarat

    2004
    - Commenced manufacturing at Mohol, Maharashtra

    2008
    - Ankleshwar plant at Gujarat inspected by US-FDA

    2012
    - Ankleshwar plant inspected by PMDA and AFSSAPS

    2013
    - Commenced manufacturing at Dahej, Gujarat
    - Ankleshwar plant inspected by COFEPRIS

    2015
    - Dahej plant inspected by US-FDA

    2016
    - Dahej plant inspected by PMDA Japan

    2018
    - Dahej plant inspected by EDQM, ANSM and US-FDA
    - Mohol plant inspected by US-FDA

    2019
    - The API business was spun off into the Company
    - Ankleshwar plant inspected by US-FDA, Health Canada and PMDA, Japan

    2021
    - Achieved milestone of 403 cumulative drug master files (DMF) registrations across multiple markets globally

    2023 -The Company had announced that its board had given the green light to divest a 75% stake in its subsidiary GLS to Nirma Ltd for a total of Rs 5,651.5 crore.

    2025 -The Company name has changed from Glenmark Life Sciences Ltd to Alivus Life Sciences Ltd. -The Company Informed regarding Agreement and Power Supply Agreement between Alivus Life Sciences Ltd. and Torrent Urja 19 Private Ltd.

    Way2Wealth Brokers Private Limited - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 | Research Analyst: SEBI Regn No. INH200008705 | PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Way2Wealth Brokers Pvt. Ltd. All rights reserved

    Designed, developed and content provided by  Dion

    Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.